Highly rated in
Highly rated in
Check Dr. Kyle T. Colvett's experience treating your condition:
About Dr. Kyle T. Colvett

Kyle Colvett is a Radiation Oncologist in Johnson City, Tennessee. Colvett has been practicing medicine for over 31 years and is highly rated in 9 conditions, according to our data. His top areas of expertise are Pleuropulmonary Blastoma, Breast Cancer, Angiosarcoma, and Familial Prostate Cancer. He is licensed to treat patients in Tennessee. Colvett is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 4 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Kyle T. Colvett it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Kyle T. Colvett accepts the following insurance:

  •  Blue Cross Blue Shield

Call to see if your plan is accepted.
400 N State Of Franklin Rd, Johnson City, TN 37604
Other Locations
Johnson City, TN 37602
300 Med Tech Pkwy, Johnson City, TN 37604
Background & Education
Graduate Institution
East Tennessee State University Quillen College Of Medicine, 1992
Radiation Oncology
Radiology in TN
Hospital Affiliations
Indian Path Community Hospital
Johnson City Medical Center
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
View 3 Less Clinical Trials -

1 Total Publications

Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors